Women & Infants Among America's Best Hospitals for Cancer Care

Release Date: 02/17/2016

Today it was announced that Women & Infants Hospital of Rhode Island, a Care New England Hospital, has received the 2016 Women’s Choice Award® as one of America’s Best Hospitals for Cancer Care for the second consecutive year. This evidence-based designation is the only cancer care award that identifies the country’s best health care institutions based on robust criteria that consider female patient satisfaction, clinical excellence, and what women say they want from a hospital.

Last month, Women & Infants was also named one of America’s Best Hospitals for Obstetrics.

The 366 award winners represent hospitals that have been accredited by the American College of Surgeons’ Commission on Cancer, signifying Women & Infants’ commitment to meeting the highest standards in cancer care.

“We are so proud of this honor and to be recognized again among some of the best hospitals in our country for cancer care,” said Mark R. Marcantano, president and chief operating officer at Women & Infants Hospital. “Our Program in Women’s Oncology is one of the nation’s leading services for the diagnosis, treatment and research of women’s cancers. We are very proud that this excellence is being recognized."

 

The 2016 America’s Best Hospitals for Cancer Care must have received accreditation from the American College of Surgeons Commission on Cancer as well as any of the following: a National Cancer Institute (NCI) Designated Comprehensive Cancer program, a Comprehensive Community Cancer Program, an Integrated Network Cancer Program, or an Academic Comprehensive Cancer Program. Selected hospitals were then given a score based on their patient recommendation rating from the Centers for Medicare and Medicaid Services’ (CMS) Hospital Consumer Assessment for Healthcare Providers and Systems (HCAHPS) survey.

 

Additional criteria considered if a hospital offered on site chemotherapy, radiation or hospice, and cancer research activities. Hospitals were penalized for having high infection rates.

 

“Women have many choices when it comes to cancer care, but now they can make informed choices based on rigorous evidence based criteria. As a cancer survivor who faced a challenging journey to recovery, I wish I had the Women’s Choice Award as a resource to spare me unnecessary fret and error,” said Delia Passi, Founder and CEO of the Women’s Choice Award.

 

 

About Women & Infants Hospital 

Women & Infants Hospital of Rhode Island, a Care New England hospital, is one of the nation’s leading specialty hospitals for women and newborns. A major teaching affiliate of The Warren Alpert Medical School of Brown University for obstetrics, gynecology and newborn pediatrics, as well as a number of specialized programs in women’s medicine, Women & Infants is the 9th largest stand-alone obstetrical service in the country and the largest in New England with approximately 8,500 deliveries per year. A Designated Baby-Friendly® USA hospital, U.S.News & World Report 2014-15 Best Children’s Hospital in Neonatology and a 2014 Leapfrog Top Hospital, in 2009 Women & Infants opened what was at the time the country’s largest, single-family room neonatal intensive care unit.

Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation’s first mother-baby perinatal psychiatric partial hospital, as well as the nation’s only fellowship program in obstetric medicine.

Women & Infants has been designated as a Breast Imaging Center of Excellence by the American College of Radiography; a Center of Excellence in Minimally Invasive Gynecology; a Center of Biomedical Research Excellence by the National Institutes of Health (NIH); and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute’s Gynecologic Oncology Group and the Pelvic Floor Disorders Network.